Infective Endocarditis: The European Viewpoint

Current Problems in Cardiology

Volumn 36, Issue 5, 2011, Pages 175-222

  Tornos, Pilar ^a   Gonzalez Alujas, Teresa ^a   Thuny, Frank ^a   Habib, Gilbert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN;

ACUTE KIDNEY FAILURE; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BLEEDING; BLOOD CULTURE; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CAUSAL ATTRIBUTION; CHEMOPROPHYLAXIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; DEFIBRILLATOR; DIABETIC PATIENT; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; GERIATRIC PATIENT; HEART ABSCESS; HEART FAILURE; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; INTERVERTEBRAL DISK DEGENERATION; LONG TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; MYCOTIC ANEURYSM; NEUROSURGERY; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT CARE; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; PROSTHESIS FAILURE; PROSTHETIC VALVE ENDOCARDITIS; RISK ASSESSMENT; SPLEEN ABSCESS; SPLENECTOMY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; VALVULOPLASTY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS; EUROPE; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS; HUMANS; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 79957516552     PISSN: 01462806     EISSN: 15356280     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2011.03.004     Document Type: Article

References (143)

1. Hoen B., Alla F., Selton-Suty C., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288:75-81.
2. Hogevik H., Olaison L., Anderson R., et al. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995, 74:324-339.
3. Berlin J.A., Abrutyn E., Storm B.L., et al. Incidence of infective endocarditis in the Delaware Valley 1988-1990. Am J Cardiol 1995, 76:933-936.
4. Van der Meer J.T., Thompson J., Valkenburg H.A., et al. Epidemiology of bacterial endocarditis in the Netherlands I. Patient characteristics. Arch Intern Med 1992, 39:101-107.
5. Askoy O., Meyer L.T., Cabell C.H., et al. Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients. Scand J Infect Dis 2007, 39:101-107.
6. Sambola A., Fernández-Hidalgo N., Almirante B., et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol 2010, 106:92-98.
7. Tleyjeh I.M., Abdel-Latif A., Rahbi H., et al. A systematic review of population-based studies of infective endocarditis. Chest 2007, 132:1025-1035.
8. Tornos P., Iung B., Permanyer-Miralda G., et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart 2005, 91:571-575.
9. Moreillon P., Que Y.A. Infective endocarditis. Lancet 2004, 363:139-149.
10. Hill E.E., Herligers P., Claus P., et al. Infective endocarditis. Changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007, 28:196-203.
11. Tleyjeh I.M., Steckelberg J.M., Murad H.S., et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County Minnesota. JAMA 2005, 293:3022-3028.
12. Cabell C.H., Jollis J.G., Peterson G.E., et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002, 162:90-94.
13. Chu V.H., Cabell C.H., Abrutyn E., et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004, 39:1527-1530.
14. Ribera E., Miro J.M., Cortes E., et al. Influence of human immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1998, 158:2043-2050.
15. Letaief A., Boughzala E., Kaabia N., et al. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis 2007, 11:230-233.
16. Nkomo V.T. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart 2007, 93:1510-1519.
17. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736-1754.
18. Nishimura R.A., Carabello B.A., Faxon D.P., et al. ACC/AHA 2008 guideline update on valvular heart disease: Focused update on infective endocarditis: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:887-896.
19. Danchin N., Dval X., Leport C. Prophylaxis of Infective endocarditis: French recommendations 2002. Heart 2005, 91:715-718.
20. Gould F.K., Elliot T.S., Forewaker J., et al. Working Party of the British Society for Animicrobial C. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006, 57:1035-1042.
21. Naber C.K., Al-Nawas B., Baumgartner B., et al. Prophylaxe der infectiösen Endokarditis. Kardiologe 2007, 1:243-250.
22. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009). Eur Heart J 2009, 19:2369-2413.
23. Anderson D.J., Olaison L., McDonald J.R., et al. Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. Eur J Clin Microbiol Infect Dis 2005, 24:665-670.
24. Lalani T., Kanafaki Z.A., Chu V.H., et al. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis-merged database. Eur J Clin Microbiol Infect Dis 2006, 25:365-368.
25. Chu V.H., Sexton D.J., Cabell C.H., et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 2005, 41:406-409. [Epub 2005 Jun 14].
26. Renzulli A., Carozza A., Romano G., et al. Recurrent infective endocarditis: a multivariate analysis of 21 years experience. Ann Thorac Surg 2001, 72:39-43.
27. Li W., Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J 1998, 19:166-173.
28. Takeda S., Nakanishi T., Nakazawa M. A 28-year trend of infective endocarditis associated with congenital heart diseases: A single institute experience. Pediatr Int 2005, 47:392-396.
29. Millar B.C., Moore J.E. Antibiotic prophylaxis, body piercing and infective endocarditis. J Antimicrob Chemother 2004, 53:123-126.
30. Yoshinaga M., Niwa K., Niwa A., et al. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol 2008, 101:114-118.
31. Thilén U. Infective endocarditis in adults with congenital heart disease. Curr Infect Dis Rep 2003, 5:300-306.
32. Fernández-Hidalgo N., Almirante B., Tornos P., et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008, 47:1287-1297.
33. Fowler V.G., Miro J.M., Hoen B., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
34. Chu V.H., Woods C.W., Miro J.M., et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008, 46:232-242.
35. Revilla A., San Román J.A., López J., et al. [Current profile of left-sided native valve endocarditis caused by coagulase-negative Staphylococcus]. Rev Esp Cardiol 2005, 58:749-752.
36. Richardson D.C., Burrows L.L., Korithoski B., et al. Tropheryma whippelli as a cause of afebrile culture-negative endocarditis: the evolving spectrum of Whipple's disease. J Infect 2003, 47:170-173.
37. Durack D.T., Lukes A.S., Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200-209.
38. Fournier P.E., Casalta J.P., Habib G., et al. Modification of the diagnostic criteria proposed by the Duke Endocarditis service to permit improved diagnosis of Q fever endocarditis. Am J Med 1999, 100:629-633.
39. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
40. Prendergast B.D. Diagnostic criteria and problems in infective endocarditis. Heart 2004, 90:611-613.
41. Prendergast B.D. The changing face of infective endocarditis. Heart 2006, 92:879-885.
42. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e1-e142.
43. Petti C.A., Fowler V.G. Staphylococcus aureus bacteremia and endocarditis. Cardiol Clin 2003, 21:219-233. vii.
44. Pérez de Isla L., Zamorano J., Lennie V., et al. Negative blood culture infective endocarditis in the elderly: Long-term follow-up. Gerontology 2007, 53:245-249.
45. Thuny F., Di Salvo G., Beillard O., et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: A prospective multicenter study. Circulation 2005, 112:69-75.
46. Greaves K., Mou D., Patel A., et al. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003, 89:273-275.
47. Evangelista A., Gonzàlez-Alujas M.T. Echocardiography in infective endocarditis. Heart 2004, 90:614-617.
48. Winslow T., Foster E., Adams J.R., et al. Pulmonary valve endocarditis: improved diagnosis with biplane transesophageal echocardiography. J Am Soc Echocardiogr 1992, 5:206-210.
49. Klug D., Lacroix D., Savoye C., et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997, 95:2098-2107.
50. Sochowski R.A., Chan K.L. Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. J Am Coll Cardiol 1993, 21:216-221.
51. Hill E.E., Herijgers P., Claus P., et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome a 5 year study. Am Heart J 2007, 154:923-928.
52. Feuchtner G.M., Stolzmann P., Dichtl W., et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol 2009, 53:436-444.
53. Vieira M.L., Grinberg M., Pomerantzelff P.M., et al. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart 2004, 90:1020-1024.
54. Shapira Y., Weisenberg D.E., Vaturi M., et al. The impact of intraoperative transesophageal echocardiography in infective endocarditis. Isr Med Assoc J 2007, 9:299-302.
55. Raoult D., Casalta J.P., Richet H., et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 2005, 43:5238-5242.
56. Delahaye F., Rial M.O., de Gevigney G., et al. A critical appraisal of the quality of the management of infective endocarditis. J Am Coll Cardiol 1999, 33:788-793.
57. Baron E.J., Scott J.D., Tompkins L.S. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clin Infect Dis 2005, 41:1677-1680.
58. Brouqui P., Raoult D. New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol Med Microbiol 2006, 47:1-13.
59. Lamas C.C., Eykyn S.J. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 2003, 89:258-262.
60. Watkin R.W., Lang S., Lambert P.A., et al. The serological diagnosis of staphylococcal infective endocarditis. J Infect Dis 2006, 53:301-307.
61. Millar B.C., Moore J.E. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 2004, 23:353-365.
62. Breitkopf C., Hammel D., Scheld H.H., et al. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 2005, 111:1415-1421.
63. Rovery C., Greub G., Lepidi H., et al. PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 2005, 43:163-167.
64. Branger S., Casalta J.P., Habib G., et al. Streptococcus pneumoniae endocarditis: persistence of DNA on heart valve material 7 years after infectious episode. J Clin Microbiol 2003, 41:4435-4437.
65. Fenollar F., Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 2007, 30(Suppl 1):s7-s15.
66. Fenollar F., Goncalves A., Esterni B., et al. A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. J Infect Dis 2006, 194:1356-1366.
67. Millar B., Moore J., Mallon P., et al. Molecular diagnosis of infective endocarditis-a new Duke's criterion. Scand J Infect Dis 2001, 33:673-680.
68. Fernández-Hidalgo N., Almirante B., Tornos P., et al. Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital. Prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 2011, 17:769-775.
69. San Roman J.A., Lopez J., Vilacosta I., et al. Prognostic tratification of patients with left sided endocarditis determined at admission. Am J Med 2007, 120:e1-e7.
70. Chu V.H., Cabell C.H., Benjamin D.K., et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004, 109:1745-1749.
71. Morris A.J., Drinković D., Pottumarthy S., et al. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005, 41:187-194.
72. Monteiro C.A., Cobbs C.G. Outpatient management of infective endocarditis. Curr Infect Dis Rep 2001, 3:319-327.
73. Huminer D., Bishara J., Pitlik S. Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis 1999, 18:330-334.
74. Di Salvo G., Thuny F., Rosenberg V., et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J 2003, 24:1576-1583.
75. Hasbun R., Vikram H.R., Barakat L.A., et al. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003, 289:1933-1940.
76. Kahveci G., Bayrak F., Mutlu B., et al. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am J Cardiol 2007, 99:1429-1433.
77. Revilla A., Lopez J., López J., Vilacosta I., et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J 2007, 28:65-71.
78. Rohmann S., Erbel R., Darius H., Gorge G., et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991, 4:465-474.
79. Anguera I., Miro J.M., Vilacosta I., et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005, 26:288-297.
80. Anguera I., Miro J.M., San Roman J.A., et al. Periannular complications in infective endocarditis involving prosthetic aortic valves. Am J Cardiol 2006, 98:1261-1268.
81. Anguera I., Miro J.M., Evangelista A., et al. Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol 2006, 98:1254-1260.
82. Vilacosta I., Graupner C., San Román J.A., et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002, 39:1489-1495.
83. Cooper H.A., Thompson E.C., Laureno R., et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 2009, 120:585-591.
84. Thuny F., Avierinos J.F., Tribouilloy C., et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 2007, 28:1155-1161.
85. Snygg-Martin U., Gustafsson L., Rosengren L., et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008, 47:23-30.
86. Duval X., Iung B., Klein I., et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010, 152:497-504. W175.
87. Steckelberg J.M., Murphy J.G., Ballard D., et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991, 114:635-640.
88. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28:230-268.
89. Dreyfus G., Serraf A., Jebara V.A., et al. Pet al. Ann Thorac Surg 1990, 49:706-711. [Discussion 712-3].
90. Takkenberg J.J., Klieverik L.M., Bekkers J.A., et al. Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study. Eur J Cardiothorac Surg 2007, 31:851-859.
91. Krasopoulos G., David T.E., Armstrong S. Custom-tailored valved conduit for complex aortic root disease. J Thorac Cardiovasc Surg 2008, 135:3-7.
92. Sabik J.F., Lytle B.W., Blackstone E.H., et al. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002, 74:650-659.
93. Lopes S., Calvinho P., de Oliveira F., et al. Allograft aortic root replacement in complex prosthetic endocarditis. Eur J Cardiothorac Surg 2007, 32:126-130. [Discussion 131-2].
94. Schmidtke C., Dahmen G., Sievers H.H. Subcoronary Ross procedure in patients with active endocarditis. Ann Thorac Surg 2007, 83:36-39.
95. Prat A., Fabre O.H., Vincentelli A., et al. Ross operation and mitral homograft for aortic and tricuspid valve endocarditis. Ann Thorac Surg 1998, 65:1450-1452.
96. Delay D., Pellerin M., Carrier M., et al. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg 2000, 70:1219-1223.
97. Thuny F., Beurtheret S., Gariboldi V., et al. Outcome after surgical treatment performed within the first week of antimicrobial therapy during infective endocarditis: a prospective study. Arch Cardiovasc Dis 2008, 101:687-695.
98. David T.E., Gavra G., Feindel C.M., et al. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 2007, 133:144-149.
99. Alexiou C., Langley S.M., Stafford H., et al. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000, 69:1448-1454.
100. Heiro M., Nikoskelainen J., Engblom E., et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000, 160:2781-2787.
101. Piper C., Wiemer M., Schulte H.D., et al. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001, 10:703-711.
102. Eishi K., Kawazoe K., Kuriyama Y., et al. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995, 110:1745-1755.
103. Ruttmann E., Willeit J., Ulmer H., et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006, 37:2094-2099.
104. Corr P., Wright M., Handler L.C. Endocarditis-related cerebral aneurysms: radiologic changes with treatment. AJNR Am J Neuroradiol 1995, 16:745-748.
105. Pruitt A.A., Rubin R.H., Karchmer A.W., et al. Neurologic complications of bacterial endocarditis. Medicine (Baltimore) 1978, 57:329-343.
106. White P.M., Teasdale E.M., Wardlaw J.M., et al. Intracranial aneurysms: CT angiography and MR angiography for detection prospective blinded comparison in a large patient cohort. Radiology 2001, 219:739-749.
107. Huston J., Nichols D.A., Luetmer P.H., et al. Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol 1994, 15:1607-1614.
108. Ahmadi J., Tung H., Giannotta S.L., et al. Monitoring of infectious intracranial aneurysms by sequential computed tomographic/magnetic resonance imaging studies. Neurosurgery 1993, 32:45-49. [Discussion 49-50].
109. Chapot R., Houdart E., Saint-Maurice J.P., et al. Endovascular treatment of cerebral mycotic aneurysms. Radiology 2002, 222:389-396.
110. Majumdar A., Chowdhary S., Ferreira M.A., et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant 2000, 15:1782-1787.
111. Conlon P.J., Jefferies F., Krigman H.R., et al. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 1998, 49:96-101.
112. Pigrau C., Almirante B., Flores X., et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med 2005, 118:1287.
113. Chou Y.H., Hsu C.C., Tiu C.M., et al. Splenic abscess: sonographic diagnosis and percutaneous drainage or aspiration. Gastrointest Radiol 1992, 17:262-266.
114. Lerner R.M., Spataro R.F. Splenic abscess: percutaneous drainage. Radiology 1984, 153:643-645.
115. Vongpatanasin W., Hillis L.D., Lange R.A. Prosthetic heart valves. N Engl J Med 1996, 335:407-416.
116. Habib G., Thuny F., Avierinos J.F. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis 2008, 50:274-281.
117. López J., Revilla A., Vilacosta I., et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007, 28:760-765.
118. Habib G., Derumeaux G., Avierinos J.F., et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 1999, 33:2023-2029.
119. Habib G. Management of infective endocarditis. Heart 2006, 92:124-130.
120. Lamas C.C., Eykyn S.J. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 1997, 25:713-719.
121. Habib G., Tribouilloy C., Thuny F., et al. Prosthetic valve endocarditis: who needs surgery?. A multicentre study of 104 cases. Heart 2005, 91:954-959.
122. Sohail M.R., Martin K.R., Wilson W.R., et al. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med 2006, 119:147-154.
123. Rundström H., Kennergren C., Andersson R., et al. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis 2004, 36:674-679.
124. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Circulation 2003, 108:2015-2031.
125. Duval X., Selton-Suty C., Alla F., et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004, 39:68-74.
126. Mathew J., Addai T., Anand A., et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995, 155:1641-1648.
127. Vilacosta I., Sarriá C., San Román J.A., et al. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994, 89:2684-2687.
128. Sohail M.R., Uslan D.Z., Khan A.H., et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008, 83:46-53.
129. Love C.J., Wilkoff B.L., Byrd C.L., et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000, 23:544-551.
130. Ruttmann E., Hangler H.B., Kilo J., et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 2006, 29:231-236.
131. Jenkins S.M., Hawkins N.M., Hogg K.J. Pacemaker endocarditis in patients with prosthetic valve replacements: case trilogy and literature review. Pacing Clin Electrophysiol 2007, 30:1279-1283.
132. Frontera J.A., Gradon J.D. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000, 30:374-379.
133. Miró J.M., del Rio A., Mestres C.A. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003, 21:167-184.
134. San Román J.A., Vilacosta I. Role of transesophageal echocardiography in right-sided endocarditis. Echocardiography 1995, 12:669-672.
135. Ribera E., Gómez-Jimenez J., Cortes E., et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 1996, 125:969-974.
136. Hecht S.R., Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992, 117:560-566.
137. Pettersson G., Carbon C. Recommendations for the surgical treatment of endocarditis. Clin Microbiol Infect 1998, 4(Suppl 3):S34-S46.
138. Moons P., De Volder E., Budts W., et al. What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications?. A call for structured patient education. Heart 2001, 86:74-80.
139. Selton-Suty C., Hoen B., Grentzinger A., et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart 1997, 77:260-263.
140. Durante-Mangoni E., Bradley S., Selton-Suty C., et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008, 168:2095-2103.
141. Hoen B., Chirouze C., Cabell C.H., et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 2005, 24:12-16.
142. Pergola V., Di Salvo G., Habib G., et al. Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol 2001, 88:871-875.
143. McDonald J.R., Olaison L., Anderson D.J., et al. Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med 2005, 118:759-766.